Page last updated: 2024-12-08

3-(2'-pyridyldithio)benzyldiazoacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(2'-pyridyldithio)benzyldiazoacetate: structure given in first source; isomeric probe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID195202
MeSH IDM0159044

Synonyms (7)

Synonym
mpda
117141-31-8
m-(2'-pyridyldithio)benzyldiazoacetate
3-(2'-pyridyldithio)benzyldiazoacetate
GTIBIXIJABCLPL-NTEUORMPSA-N ,
[3-(pyridin-2-yldisulfanyl)phenyl]methyl 2-diazoacetate
AKOS040749935

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The results provided new evidence that MPDA was safe to use in large doses via different drug delivery means, and this lays the foundation for further clinical applications."( Toxicity Analysis of Mesoporous Polydopamine on Intestinal Tissue and Microflora.
Huang, Z; Li, Q; Liao, Y; Liu, C; Liu, Y; Shi, L; Xie, L; Yuan, M, 2022
)
0.72
" Henceforth, we aimed to seek a strategy to reduce the toxic effects of this combination by taking advantage of the mesoporous polydopamine (MPDA) nanoparticles with good biocompatibility and high drug loading capacity."( Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity.
Chen, G; Fan, J; Fu, Y; Guo, E; Hu, D; Hu, X; Li, Z; Liu, C; Lu, F; Qin, T; Qin, X; Sun, C; Wang, W; Xiao, R; Xiong, Y; Yang, B; Zhang, L, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
" Herein, an efficient nanoplatform for near-infrared (NIR)-light-controlled release and bacteria-targeted delivery of nitric oxide (NO) combined with photothermal therapy (PTT) is presented."( Bacteria-Targeted Combined with Photothermal/NO Nanoparticles for the Treatment and Diagnosis of MRSA Infection In Vivo.
Chen, Z; Li, G; Liu, L; Lv, K; Ma, D; Pan, X; Xu, H; Zhang, Y, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.94)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (2.94)24.3611
2020's32 (94.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.76 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index6.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]